At the time, many people probably assumed that Fauci and the CDC simply miscalculated when they ignored their own experts, flattened the curve, and prolonged the outbreak.  But more recent evidence that Fauci's agency was already working on developing a COVID vaccine when those decisions were made public suggests that slowing down the pandemic was also necessary for their vaccine to qualify as the weapon of choice when it became available.  Although widely dismissed as yet another "conspiracy theory" undeserving of serious consideration, this truly sinister fantasy merely re-emphasizes the established fact that developing and promoting new vaccines in partnership with the drug industry had long since become Fauci's and the CDC's default strategy for dealing with acute infectious diseases of every kind.7

The rehearsal.

That possibility gained even more traction when we learned that CDC officials had actively participated in an elaborate wargame exercise in October of 2019, just 2 months before the first recorded case, uncannily simulating a coronavirus pandemic like the one we are still struggling through.8   Organized jointly by the futuristic World Economic Forum, the Bill and Melinda Gates Foundation, and the Johns Hopkins Center for Health Security, the so-called "Event 201" was staged at New York's Hotel Pierre, and invited legislators, health policy makers, representatives of print and social media, corporate executives, CIA officials, and even the head of China's CDC to attend.  It envisioned a global health crisis involving 65,000,000 deaths and a massive economic shutdown lasting 18 months, until either an effective vaccine became available, or 80-90% of the world's population had been exposed and developed natural herd immunity, whichever came first.
Of course, flattening the curve was already eliminating the second possibility, and even made it seem undesirable, as Dr. Fauci later admitted, since those who achieved natural immunity might no longer want or seem to need vaccines like the one his agency was actively developing.10   The organizers also laid particular emphasis on the indispensable role of the media in dispelling panic, by suppressing "misinformation" and "disinformation" at variance with the official narrative and the draconian measures needed to quell the outbreak.11

In late January, just 4 weeks after the first declared Wuhan case, the World Economic Forum announced its own COVID Action Platform, an international consortium for expediting vaccine development and mandating their use; and, a few days later, the World Health Organization declared a global Public Health Emergency, signing on to precisely the same 18-month scenario that the organizers of Event 201 had already mapped out,12 thus preparing the way for locking down, requiring masks, closing schools and businesses, and vaccinating as much of the whole world as soon as possible.  The presence of China's top public health official provided further fuel for suspecting that Event 201 was no mere simulation, but in fact a dress rehearsal for the momentous events that the organizers knew had already begun and were about to astonish the world.  

    3. The Illness

The broad outlines of the COVID-19 illness soon made themselves known.  In the months immediately following the lockdown, the extreme mutability of the SARS-CoV-2 virus became evident in the biphasic cycles of sharp declines in the number of reported cases in various parts of the world, followed by equally dramatic surges of new cases linked to genetic variants and subvariants of the original virus.13,14,15   These mutant strains have proved even more numerous and have appeared even more rapidly than with the influenza viruses, which likewise require much guesswork in predicting and redesigning vaccines against them on a yearly basis even before they emerge.

An even more striking pattern was the extent to which the deaths and most severe cases requiring hospitalization were occurring consistently and predominantly among the elderly and chronically ill, an affinity that had been noticed to some extent in past outbreaks, but never so predominantly as to seem almost aimed at them.  As of March, 2020, almost 2500 Italians had already died while testing positive for the virus, and over 99% of them were already suffering with various chronic diseases: 25% with one, 26% more with two, and 49% more with 3 and up, but less than 1% with none; their average age was 79.5 years.16  Right from the start, the outbreak was sending an unmistakable and dire warning to pay the most careful attention to our underlying burden of chronic disease, the terrain that was giving it life.                                                      

At least in the developed world, the illness continued targeting the elderly and chronically ill with remarkable consistency throughout 2020, and indeed has done so ever since.  In the U. S., residents of nursing homes, assisted-living, rehab, and other extended-care facilities comprised only 0.6% of the population, but accounted for fully 42% of all the deaths linked to COVD-19 in 2020, and a lot more than that in many states, e. g., 81.4% in Minnesota, 77.0 in Rhode Island, and 70.0% in Ohio.17  Along the same lines, 86.2% of Americans dying while testing positive for COVID-19 were already suffering from one or more chronic diseases;18 and a large preponderance of all COVID-related deaths worldwide likewise involved comorbidities,19 ,creating a similar confusion as to whether the virus was the immediate cause of death, or a secondary, contributing factor, or only a coincidence.20,21   

As it happens, the cause of death as recorded on U. S. death certificates was then and is still simply accepted at face value by the CDC, and included in its statistics without further review, thus adding still more reason to question their accuracy, as the agency itself admitted:

COVID-19 should not be reported on the death certificate if it did not cause or contribute to the death. [Ascertaining proper] cause of death can be challenging,  especially during emergencies [if] certifiers face heavy workloads, lack access to complete information, [or are] not well   trained in [certifying] the cause of death. Current estimates are that 20-30% of death certificates have [such] issues.22        

Is COVID-19 a chronic disease?

The revelation that COVID-19 cases and deaths were occurring predominantly in people who were already chronically ill prompted me to wonder if the baseline effect of the illness might include simply making worse whatever other chronic illnesses were already present, the nonspecific, baseline effect of vaccination that I had observed repeatedly in my years of practice and often written about.23  That possibility also alerted me to other peculiar and distinctly unusual characteristics of the disease.  First of all, even though many of the most severe cases making the headlines and overcrowding Emergency Rooms and ICUs were identified as an unusual type of Acute Respiratory Distress Syndrome, or ARDS, involving marked deoxygenation of the blood,24 many other serious and fatal cases spared the lungs entirely, and produced microscopic blood clots in a variety of other organs and tissues.25                                                                                                                    

Secondly, no matter which organs were involved, autopsies consistently revealed signs of "cytokine storm" or lesser degrees of autoimmune dysregulation, involving excessively high levels of interleukins and autoantibodies in the damaged cells and tissues.26   Finally, as many as 20-30% of patients with active COVID-19 develop a similarly wide variety of signs and symptoms that persist chronically for months or even longer, and often prove refractory to treatment.27  Originally assumed to be simply residues of the acute phase, these conditions have actually behaved more like chronic diseases in their own right, exhibiting lesser degrees of the same type of autoimmune dysregulation, and even developing in quite a few patients who had seemingly recovered or been only mildly ill until then.28                                                                                                                      

In all three respects, this broad array of COVID-19 illness presentations have resembled the other chronic diseases we're already much too familiar with, exhibiting a slow, persistent course punctuated by acute phases and flare-ups, and characterized by varying degrees of autoimmune dysregulation in the severe and fatal cases as well as the "long-COVID" version.  From that perspective, even those numerous cases thought to be reinfections might simply be flare-ups of the original illness in its chronic form.     A further indication of chronicity lay in the disease's other major clustering of cases, hospitalizations, and fatalities among society's least fortunate, those handicapped by poverty, discrimination, malnutrition, homelessness, overcrowding, and the like,29 in parallel with the other chronic diseases that already burden Americans more than anyone else in the  developed world.30  The added cascade of impoverishment and job loss precipitated by the lockdown undoubtedly help explain why our death rate from COVID-19 continues to outnumber everyone else's, and why the pandemic as a whole will almost certainly exacerbate these same trends still further in the future.

The Emergency.

Originally justified on the basis of the WHO's declaration of emergency, the lockdown quickly ripened into a self-fulfilling prophecy, with the economic collapse and social isolation of masking, distancing, and "sheltering in place" instigating a bona fide emergency of job loss, impoverishment, and social isolation that was much worse than anything the disease itself would have been capable of if properly managed, and continues to haunt us even now, when most of the original technical restrictions are being lifted or ignored.                                                                                                                                 

Many prominent epidemiologists whose initial advice was disregarded have continued to reject the official mythology, based on the large but unknown and indeed unknowable number of asymptomatic or only mildly symptomatic cases who never sought testing or needed treatment.  As early as March, 2020, Prof. John Ioannidis of Stanford designed a study to address that uncertainty by testing a broad cross-section of several thousand residents in Santa Clara County, California for SARS-CoV-2 antibodies, indicating previous infection with the virus.  By extrapolating from that large sample, the authors calculated that roughly 53,000 residents, an estimated 2.8% of the population, had already been infected, a number more than 44 times the less-than-1200 confirmed cases at the time,31 yielding a death rate of approximately 0.17% overall,32 roughly comparable to that of an average flu season requiring no such restrictions.  Similar discrepancies were also documented elsewhere,33 but in most places the higher case fatality rate based on clearly symptomatic cases was retained as the standard, reaffirming the emergency.

The Treatment

As we saw, the CDC and WHO made clear from the beginning that dealing with the pandemic would be focused primarily on developing new vaccines against the virus, injecting them worldwide into as many people as possible, and pressuring governments across the world to mandate them for their entire populations.  On the face of it, that strategy reflected the general view that treating viral infections with medicines wasn't very effective anyway, with symptomatic relief the best that could be hoped for.  But when the pandemic was declared, no vaccines had yet been developed against it.  Even at the breakneck pace of Operation Warp Speed that the leading manufacturers and even President Trump were pushing for, none would be available until the end of 2020 at the earliest.  In addition, all previous vaccines were designed to be given to healthy people to prevent infections from breaking out in the future; never before had they been given in the midst of an outbreak to people who were at high risk of being infected or had already fallen ill and recovered.

So we were told and indeed ordered to protect ourselves by staying home all the time, masking and social distancing when going out in public, and staying away from the hospital except when significantly ill and needing treatment, when we would qualify for remdesivir, a high-priced antiviral, developed by Fauci's own team at NIH,34,35 and ventilator therapy with oxygen at high pressure, both of which were life-threatening all by themselves.  In short, virtually the entire populations of our own and many other developed countries were offered no preventive care or treatment whatsoever for close to an entire year, even though several inexpensive, non-toxic therapies of proven effectiveness were readily available, and physicians and health professionals were actually using them on their own with notable success.                                                                                

One such was Chinese herbal medicine, with thousands of years of history and experience behind it, and many studies in accredited journals attesting to its value in treating COVID-19.36  Several American physicians likewise reported excellent success in both preventing and treating the disease with high doses of nutritional supplements, such as Dr. David Brownstein's regimen of oral Vitamins A, C, D, and iodine, plus IV infusions of the same for seriously ill patients in the hospital.37  In an early series of 520 confirmed, symptomatic cases, he reported only 9 hospitalizations and not a single death.38                               

Hydrochloroquine and ivermectin.                                                                     

Hydroxychloroquine or Plaquenil, an inexpensive, widely-used antimalarial and anti-inflammatory drug with an excellent safety record, was also proving extremely beneficial to many patients in the early stages of the pandemic, and backed by several peer-reviewed studies recommending its use.  Prof. Harvey Risch, an epidemiologist at Yale, concluded a meta-analysis of five different outpatient trials with an urgent plea for widespread use of the drug in combination with zinc and azithromycin at the onset of symptoms, as a safe, inexpensive, and extremely effective method for ending the pandemic.39                                                                                                                                                     

Ivermectin, a similarly inexpensive and widely available anti-parasitic drug with a notable record of safety and efficacy against hookworm, roundworms, and filariasis, had already earned a Nobel Prize for its developers.  When the Peruvian government began distributing it to various subpopulations at high risk, the death rate from COVID dropped precipitously in those regions.40   Testifying before a Senate Committee, Pierre Kory, M. D., a lung and critical-care-specialist, cited RCTs involving thousands of hospitalized patients that demonstrated remarkably higher rates of recovery and proportionately lower death rates after treatment with Ivermectin.41

Homeopathy.   

Although widely ignored and even ridiculed by many physicians, homeopathic medicine, my own subspecialty for 46 years, has been in continuous use for more than two centuries, with an impressive track record in both preventing and treating outbreaks of scarlet fever, cholera, typhoid, yellow fever, influenza, and other epidemic diseases in the past.42  In Kerala, a populous state in south India with only 23 confirmed deaths from COVID-19 in that terrible first wave, its phenomenal success in minimizing the impact of the disease was widely ascribed to the provincial government's policy of distributing homeopathic medicines prophylactically to all residents.43   Some months later, when vaccines became available and were administered on a large scale, the number of cases and deaths rose sharply to levels more nearly comparable to those in neighboring states.44                                                                                                                                                                       

Similarly in Cuba, the government's initial response to the pandemic was to provide the homeopathic medicine Arsenicum album to all residents both preventively and as needed for treatment, with the result that in all of 2020 they recorded only 14,600 cases and 150 deaths out of a population of 11,000,000.45  But their own massive vaccination rollout in 2021 saw their numbers skyrocket to 540,000 cases, 120,000 in August alone, and 4200 deaths, figures much more in keeping with those among their neighbors.46

In Italy, 50 acutely-ill patients recovered under homeopathic treatment without a single death or hospitalization.47  Using the classical method of selecting just one medicine at a time for the whole patient, Dr. André Saine, a celebrated Canadian homeopath, treated a number of critically-ill COVID patients in a French nursing home, almost all of whom recovered and remained in stable condition.48  Compiled by the American Institute of Homeopathy, a database of several hundred cases treated classically and ranging from mild to severe demonstrated a high rate of cure using many of the same medicines most commonly employed during the usual flu season, as well as others found effective in severe cases with more severe or unusual symptoms.49

Eliminating the competition.                                                                                                              

The CDC, WHO, and the drug industry spared no effort or expense in discouraging such alternatives, no matter how promising, presumably to ensure once again that people everywhere would need and long for the vaccines as their only hope of rescue.  Inasmuch as herbal medicine, nutritional therapy, and homeopathy were outliers on the fringes of the system, the medical establishment seemed content to simply ignore them as usual.  Hydrochloroquine and ivermectin, on the other hand, were popular, inexpensive, off-patent drugs known to be safe and effective and widely available without prescription; they represented precisely the kind of immediate and practical threat to the political and commercial success of their plans that moved Fauci, the agencies, and the industry to do everything possible to discredit them and minimize their use.

Hydroxychloroquine.        
 
In the case of hydroxychloroquine, or HCQ, Fauci mounted pilot studies at his agency to show that it was ineffective against COVID-19 by the simple expedient of delaying treatment with it until day 14 of symptoms, disregarding Prof. Risch's repeated insistence that it be given at the onset or as early as possible.50  He then set about convincing the world that it was also dangerous, by administering doses he knew to be excessive to elderly COVID patients in the hospital, 2400 mg. on the first day, six times the dose stipulated by Dr. Risch, followed by a double dose of 800 mg. daily thereafter, with the predictable result that several of them died.51  Fauci not only escaped censure and punishment for these misdeeds, but succeeded in convincing a credulous public and adoring media that HCQ was indeed a dangerous drug, overriding its unblemished safety record of 65 years. The sheer improbability of that achievement provides eloquent testimony to the ruthless, machine-like efficiency of the bureaucratic empire that he had built and run for the last 35 years. We taxpayers who fund his agency surely deserve to know how he managed to enlist reputable, accomplished scientists and government officials to carry out studies that they knew or should have known were fraudulent and life-threatening, not to mention overawing the world's most prestigious medical journals into signing off on their results.52                                                                                 

Precisely how he pulled that off is impressively detailed in Robert F. Kennedy Jr.'s 2021 chilling, thoroughly-documented exposé, The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health.53  As director of the NIAID, he eventually gained control of the entire Federal health bureaucracy and its all-important role of overseeing all medical research, simply by partnering with the drug industry, co-sponsoring and co-funding its scientists, and prioritizing its values, chiefly developing new, expensive, and patentable drugs and vaccines.  In so doing, he won huge increases in his agency's budget as well as significant royalties and emoluments for himself and his research team. The inevitable result was luring NIAID, its scientists, and other affiliated agencies away from their original mission of protecting the public health into simply promoting the commercial interests of the industry they were intended to regulate, a metamorphosis entirely comparable to the corrupting of many other government agencies that now happily serve the corporations they were meant to supervise.                                                                                                                                                                                                 
In the 2000s, after several decades of directing NIAID, Fauci sought to extend his influence internationally by entering into a similarly momentous and lucrative partnership with WHO and the Bill and Melinda Gates Foundation.  With their help, the giant multi-nationals of the drug industry were already prevailing on governments around the world to stop using HCQ as early as January 2020, even before the WHO had declared the COVID to be a pandemic and full-blown emergency. The U.S. and many other governments complied by first reclassifying the drug "for prescription only," then ordering doctors not to prescribe it, and, for good measure, even suspending their licenses if they disobeyed.54,55  Finally, the agencies and manufacturers pressured social and mainstream media, many of which were indebted to the same wealthy donors, to censor any information that contradicted or even questioned the approved narrative, and to keep the airwaves, print media, and internet flooded with more suitable texts provided by government agencies controlled by Fauci and funded by Gates.56 Thus RFK Jr.’s well-researched book, a runaway best-seller online, has been boycotted as disinformation everywhere else, without even being reviewed by mainstream print or broadcast media, or displayed on bookstore shelves. Yet reputable RCTs attesting to HCQ's effectiveness have continued to appear,57 and the poorer countries that made it freely available to their populations have experienced consistently lower death rates than wealthier countries like Holland, Belgium, France, Spain, the U.S., and Canada, where it was banned,58,59

Ivermectin.                                                                                                                                                        

Ivermectin's track record was even more impressive, but didn’t spare it from meeting the same fate. Ten years earlier, its extraordinary success in treating several parasitic diseases had convinced the FDA to recommend it as safe and effective, while the WHO listed it as an "essential medicine," one suitable to be given prophylactically to entire populations.60   When animal studies confirmed that the drug also got rid of SARS-CoV-2, lab experiments demonstrated that it actually bound to the virus' spike protein,61 and thereby blocked the pathogen from entering and attacking host cells. This remarkable affinity promised to make it effective for prophylaxis and treatment against not only the original SARS-CoV-2, but also its rapidly-growing list of variants, as well as other coronaviruses both past and future, all of which depend on the spike protein for entering cells and inflicting whatever mischief they're capable of.62  Reports of ivermectin given prophylactically to health-care workers regularly exposed to the virus showed that the drug prevented COVID-19 infection in close to 100% of those who volunteered to take it, in contrast to those choosing not to take it, a high percentage of whom contracted the disease.63  A study in The Lancet added that the drug impressively reduced viral loads and the intensity and duration of symptoms in those who were already ill.64

As early as the spring of 2020, with hospitals and ICU's already overloaded with the dead and dying, Dr. Paul Marik, a prominent Professor of Critical Care Medicine, invited hundreds of colleagues from around the world to conduct research and develop treatment guidelines for treating COVID-19 patients and founded the Front Line COVID-19 Critical Care or FLCCC Alliance to publicize their findings.  In November, the pulmonologist Dr. Pierre Kory, their President and Chief Medical Officer, testified before a Senate Committee that they had accumulated sufficient data to recommend giving out ivermectin routinely to prevent serious complications in those with early or mild symptoms and help those already critically ill to recover:

Six studies with over 2400 patients showed near-perfect prevention of transmission of this virus in people exposed to [it]. Three Randomized Controlled [Trials] and multiple large case series involving over 3000 patients [showed] stunning recovery among hospitalized patients. Four large Randomized Controlled Trials involving 3000 patients all [showed] large and statistically significant reductions in mortality when treated with ivermectin.65                                     

Based on these data and the common experience of other FLCCC physicians, notably Dr. Marik, Dr. Peter McCullough, an experienced cardiologist, and Dr. Robert Malone, an influential research scientist, Dr. Kory concluded his presentation with an impassioned plea for using the drug as widely as possible for both prevention and treatment, based on their conviction that early treatment with ivermectin could have saved $1 trillion in healthcare costs and prevented millions of hospitalizations and hundreds of thousands of deaths if it had been officially approved and promoted from the beginning.66 Just 10 days after this explosive testimony, the NIH's COVID-19 Treatment Guidelines Panel, which had previously issued stern warnings against the drug, retreated ever so slightly, citing "insufficient evidence to recommend either for or against ivermectin for the treatment of COVID-19,"67 and implying at least a willingness to reconsider if more compelling evidence came to light, but still opposing it for the moment, a seemingly more judicious and even-handed position that became the official government mantra ever after.  Fauci then commissioned a new multimillion-dollar study by one of the panel members that roundly debunked Dr. Kory's claims, but again hid behind the more neutral façade of simply declining to recommend it.68                                        

In short, Fauci and his allies succeeded in keeping ivermectin away from most patients in the United States, several developed countries, and many others where his influence held sway, blithely ignoring the fact that COVID cases, hospitalizations, and deaths have consistently plummeted and remained at much lower levels wherever and whenever the drug was made freely available.69                  

1.   Holshue, M. et al., "First Case of 2019 Novel Coronavirus in the United States," New England Journal of Medicine, NEJM.org, January 31, 2020.

2. Cf., for example, Cai, J., "Indirect Viral Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020," Emerging Infectious Diseases, CDC, cdc.gov, March 15, 2020.

3. Pekar, J., "Timing the SARS-CoV-2 Index Case in Hobei Province," Science, March 18, 2021.

4. Cf., for example, Woodward, A., 'The Life and Rise of Dr. Anthony Fauci, the Public-Health Hero," Business Insider, businessinsider.com, March 27, 2020.

5. Cf. Chen, C., et al., "Key Missteps at the CDC Have Set Back Its Ability to Test the Potential Spread of the Coronavirus," ProPublica, propublica.org, February 28, 2020. 

6. "Perspectives on the Pandemic II: a Conversation with Dr. Knut Wittkowski," The Press and the Public Project, thepressandthepublic.com, April 2, 2020.

7. Vide supra, Chapter 7, pp. 193-95, and Chapter 9, pp. 263-65.

8. Cf. Professor Mary Holland, "What We Can Learn from a Pandemic Tabletop Exercise," Children's Health Defense, childrenshealthdefense.org, March 25, 2020.

9. Ibid.

10. Anthony Fauci, M. D., CNN Interview with Jim Sciutto, CNN.com, April 21, 2020.

11. Prof. Holland, op. cit.

12. Ibid.

13. "8 Strains of the Coronavirus Are Circling the Globe," USA Today, usatoday.com, March 27, 2020.

14. MacKay, D., "Los Alamos National Laboratory Team Studies New Virus Strain," Albuquerque Journal, May 6, 2020.

15. Dr. Joseph Mercola, "New Delta Variant Escalates Lockdowns," mercola.com, June 23, 2021.

16. Ebhart, T., et al., "99% of Those Who Died from Virus Had Other Illnesses," Bloomberg News, March 18, 2020.

17. Cf., for example, Roy, A., "The Most Important Coronavirus Statistic: 42% of Deaths Are from 0.6% of the Population," Forbes, May 26, 2020.

18. Frankl, R., "Comorbidities the Rule in New York's COVID-19 Deaths," The Hospitalist, the-hospitalist.org, April 18, 2020.

19. "Facts about COVID-19,"Swiss Policy Research, sprs.com, March 14, 2020, updated April 18.

20. Ibid.

21. "CDC: 94% of COVID-19 Deaths Had Underlying Medical Conditions," Microsoft News, msn.com, September 1, 2020.

22. "Understanding Death Data Quality," CDC, cdc.gov, September 14, 2021.

23. Vide supra, Chapter 8, pp. 213-221.

24. Richard Levitan, M. D., "The Infection That's Silently Killing Coronavirus Patients," New York Times, April 20, 2020.

25. "Coronavirus: 'Baffling' Observations from the Front Line," BBC News, bbc.com, May 23, 2020.

26. Melo, A., et al., "Biomarkers of Cytokine Storm as Red Flags for Severe and Fatal COVID-19 Cases," PLOS One 10:137, June 29, 2021.

27. Leonard Sigal, M. D., "What Is Causing the 'Long-Hauler' Phenomenon after COVID-19?" Cleveland Clinic Journal of Medicine 88:273, May 2021.

28. Ibid.

29. Cf., for example, "COVID-19 Is Hitting Black and Poor Communities the Hardest," The Conversation, theconversation.com, April 9, 2020; and "Address Impact of COVID-19 on Poor: Virus Outbreak Highlights Structural Inequalities," Human Rights Watch, hrw.org, March 19, 2020.

30. US Health in International Perspective: Shorter Lives, Poorer Health, National Library of Medicine, National Academy of Sciences, NIH, 2013.

31. Bendavid, E., et al., "COVID-19 Antibody Seroprevalence in Santa Clara County, California," International Journal of Epidemiology 50:410, April 2021.

32. Ibid.

33. Mohanon, M., et al., "Prevalence of SARS-CoV-2 in Karnatak, India," Journal of the AMA 325:1001, February 4, 2021.

34. Lupkin, S., "Remdesivir Priced at More than $3100 for a Course of Treatment," NPR, npr.org, May 8, 2020.

35. Mulungu, S., et al., "A Randomized Controlled Trial of Ebola Virus Therapeutics," New England Journal of Medicine 381:2293, December 12, 2019.

36. Cf., for example, Yang, Y., "Traditional Chinese Medicine in the Treatment of Patients with the New Coronavirus SARS-CoV-2," International Journal of Biological Sciences 16:1708, March 15, 2020.

37. David Brownstein, M.D., "The Right Way to Fight Viruses," Natural Way to Health Newsletter, August 2021.

38. Ibid.

39. Cf., for example, Harvey Risch, M. D., "Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should be Ramped up Immediately as Key to the Pandemic Crisis," American Journal of Epidemiology 189:1218, November 2, 2020.

40. Chamie-Quintero, J., et al., "Ivermectin for COVID-19 in Peru: 14-Fold Reduction in Nationwide Excessive Deaths," Open Science Foundation, OSF Reprints, osf.io/9egh4.

41. Testimony of Pierre Kory, M. D., to the Senate Committee on Homeland Security and Governmental Affairs, Front Line COVID-19 Critical Care Alliance (FLCCC), covid19criticalcare.com, December 2020.

42. For its exemplary record in the 1918 influenza pandemic, for example, cf. Davison, J.,and Dantas, F., "A Century of Homeopaths: Their Influence on Medicine and Health," Pharos 71:5, 2008.

43. Jordan, L., "What? Only 23 Pandemic Deaths out of 35,000,000 People in a State in India?  How Did They Do It?" The Aurum Project, aurumproject.org.au, June 6, 2020.

44. Statista, statista.com, August 16, 2021.Tamil Nadu                  Population   72,000,000     Cases  2,600,000    Deaths    34,500

        Kerala                              "           35,000,000         "      6,750,000         "        70,800

        Karnataka                        "            61,000,000        "      3,000,000         "         37,000

        Andhra Pradesh              "                50,000,000                  "      2,000,000         "         14,000

45. Cf. "Cuba Promotes Homeopathy to Fight the Coronavirus," Miami Herald, April 7, 2020, and "Cuba's Response to COVID-19: Lessons for the Future," Journal of Tourism, emeraldinsight.com, March 11, 2021.  

46. Statista, statista.com, August 19, 2021. Cf. Jamaica, with 3,000,000 inhabitants, 60,000 cases, and 13,000 deaths.

47. Valeri, A., "Symptomatic COVID-19-Positive Patients Treated by Homeopathic Physicians: an Italian Descriptive Study," Società Italiana di Medicina Omeopatica, homeomed.net, April 2020.

48. Dr. André Saine, "Case Management of the COVID-19 Patient with Homeopathy," American Institute of Homeopathy Webinar, homeopathyusa.org, May 2, 2020.

49. Peter Gold, Ed., "Comprehensive Database of COVID-19 Cases," American Institute of Homeopathy, homeopathyusa.org, Summer 2000.

50. Self, W., et al., "Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients," Journal of the AMA 324:3165, November 9, 2020.

51. Meryl Nass, M. D., "COVID-19 Has Turned Public Health into a Lethal, Patient-Killing Experimental Endeavor," Alliance for Human Research Protection, ahrp.org, June 20, 2020.

52. Cf., for example, Smith, R., "Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies," PLOS Medicine 10:1371, May 17, 2005, and Marcia Angell, M. D., The Truth about the Drug Companies, Random House, 2004.  Both sources document that the industry's corrupting control of medical journals was already decades old.

53. Robert F. Kennedy Jr., The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health, Skyhorse Publishing and Children's Health Defense, Chapter 2, pp. 117-135.

54. Ibid., pp. 24-37.

55. Cf., for example, "Doctor's Medical License Suspended over Accusations of Spreading COVID Misinformation," Newsweek, January 12, 2022.  The alleged "misinformation" was simply advocating the use of ivermectin and HCQ for prevention and treatment.

56. RFK Jr., op. cit., pp. 19-37.

57. Cf., for example, Ladapo, J., et al., "Randomized Control Trials of Early, Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death," medRxiv Preprint, medRxiv.org, and Science Gate 10:1101, August 13, 2020.

58. "COVID-19 Deaths Worldwide per One Million Population, by Country," Statista, statista.com, September 24, 2021.

59. George Fareed, M. D., "Open Letter to Dr. Anthony Fauci Regarding the Use of Hydroxychloroquine for Treating COVID-19," The Desert Review, August 13, 2020.

60. World Health Organization, "Model List of Essential Medicines," WHO, who.int/pdf, 2021.

61. Lehrer, S., and Rheinstein, P., "Ivermectin Docks to the SARS-CoV-2 Spike Receptor- Binding Domain Attached to ACE2," In Vivo 34:3023, September-October 2020.

62. Santin, A., et al., "Ivermectin: a Multi-Faceted Drug of Nobel Prize-Honoured Distinction with Indicated Efficacy against a New Global Scourge," New Microbes, New Infections, August 3, 2021.

63. Cf., for example, Carvallo, H., et al., Journal of Biomedical Research and Clinical Investigation, November 17, 2020, and Alam, M., et al., European Journal of Medical and Health Sciences, December 15, 2020.  Dr. Carvallo conducted an RCT involving 788 health workers in Argentina who volunteered to receive ivermectin once a week, none of whom developed COVID-19 despite repeated exposure to it, and 407 who refused the drug, 58% of whom became ill with the disease.  Similarly, Dr. Alam gave a minimal dose of 12 mg. once a month for 4 months to 58 hospital workers in Bangladesh, only 4 of whom developed mild symptoms, compared to 60 controls who did not take it, and 44 of whom became symptomatic with the disease.

64. Chaccour, C., "The Effect of Early Treatment with Ivermectin on Viral Load, Symptoms, and Humoral Response in Patients with Non-Severe COVID-19," The Lancet 32:1007, January 19, 2021.

65. Vide supra, note 41.

66. Ibid.

67. "NIH Updates Its Position on Ivermectin," COVID-19 News and Policy Analysis, covexit.com, January 14, 2021.

68. "Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19," NIH News Release, April 19, 2021.

69. Cf. India, for example: "Media Mum on India's Ivermectin Success Story," World Tribune, September 19, 2021; Justus Hope, M. D., "Ivermectin Obliterates 97% of Delhi Cases," Desert Review, June 1, 2021; and Dr. Hope, "Tamil Nadu Leads India in New Infections, Denies Citizens Ivermectin," Desert Review, May 21, 2021.